Steven I. Park

MD, Lymphoma Program, Associate Professor, School of Medicine, University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center, Clinical Research

Steven I. Park


Director of Lymphoma Program

Associate Professor of Medicine

Leukemia, Lymphoma, and Myeloma Program

170 Manning Drive, CB#7305

Area of Clinical Interest

Non-Hodgkin Lymphoma, Hodgkin Lymphoma, and Chronic Lymphocytic Leukemia

Area of Research Interest

My research is primarily focused on targeted therapy for non-Hodgkin lymphoma. My group has examined various signaling pathways, including PI3K/mTOR and Myc, and their impact on the initiation and progression of lymphoma. We have performed translational research to uncover the mechanism of drug resistance and develop potent combinations of small molecule inhibitors against key targetable pathways in lymphoma. We hope this targeted approach against signaling pathways will enhance the efficacy of most traditional chemotherapeutics for treatment of lymphoma.

Awards and Honors

1996 - The Highest Distinction in General Scholarship, University of California, Berkeley

1999 - Deans Research Fellowship, University of California, Davis, School of Medicine

1999 - American Cancer Society Predoctoral Fellowship Award

2008 - Lymphoma Research Foundation Fellowship Award

2009 - Senior Fellow, University of Washington and Fred Hutchinson Cancer Research Center

2010 - KL2 - Interdisciplinary Clinical Research Career Development Award, NIH/UNC Clinical Translation Science Award (CTSA)

2012 - Center for AIDS Research Award

2014 - Center of Cancer Nanotechnology of Excellence Pilot Grant

2015 - American Cancer Society Mentored Research Scholar Grant (ACS-MRSG) Award in Applied and Clinical Research, Tumor Biology and Genomics 

Link to Publications on Reach NC site

Find publications on Pubmed